【结 构 式】 |
【药物名称】Remacemide hydrochloride, FPL-12924AA, PR-1032-646 [(-)-isomer], PR-1032-644 [(+)-isomer], PR-934-423A 【化学名称】(±)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide hydrochloride 【CA登记号】128298-28-2 (free base), 111686-79-4 (monoHCl) 【 分 子 式 】C17H21ClN2O 【 分 子 量 】304.82272 |
【开发单位】AstraZeneca (Originator) 【药理作用】Antiepileptic Drugs, Antiparkinsonian Drugs, Extrapyramidal Disorders, Treatment of, Huntington's Disease, Treatment of, NEUROLOGIC DRUGS, NMDA Antagonists |
合成路线1
The syntheses of remacemide [13C]-, [14C]-, [2H]-,and [3H]-labeled in several different positions have been described: The Friedel Crafts condensation of benzene with acetyl chloride (II) by means of AlCl3 in CS2 gives acetophenone (III), which by a Grignard condensation with benzylmagnesium chloride (IV) in THF yields 1,2-diphenyl-3-propanol (V). Reaction of (V) with NaCN and sulfuric acid in acetic acid affords the formamide (VI), which is hydrolyzed with refluxing aqueous HCl to give the amine (VII). The condensation of (VII) with N-Boc-glycine (VIII) and DCC or with the N-Boc-glycine mixed anhydride (IX) and TEA in dichloromethane yields the protected glycinamide (X), which is finally deprotected with HCl in refluxing methanol. Alternatively, condensation of amine (VII) with chloroacetyl chloride (XI) by means of pyridine in dichloromethane provides the chloroacetamide (XII), which is finally treated with ammonia in ethanol/dichloromethane. In this reaction sequence, the use of [carbonyl-14C]-acetophenone (III), [13C6]-benzene (I), [13C2]-acetyl chloride (II), the [1-13C]-glycines (VIII) and (IX) or the [2-3H]-glycine (VIII) as starting materials affords remacemide labeled in the corresponding positions. [2H or 3H]-remacemide labeled in 2,6-positions of the 1-phenyl ring is obtained by submitting the amine (VII) to isotopic exchange with 2H2O/RhCl3, 2H2/Iridium complex, or 3H2/Iridium complex.
【1】 Dawson, G.E.; Coombs, M.E.; Fedorchuk, M.; et al.; Preparation of remacemide hydrochloride labelled with carbon-14, carbon-13, deuterium and tritium. J Label Compd Radiopharm 2000, 43, 6, 533. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13364 | Benzene | 71-43-2 | C6H6 | 详情 | 详情 |
(II) | 19273 | acetyl chloride | 75-36-5 | C2H3ClO | 详情 | 详情 |
(III) | 10317 | Acetophenone | 98-86-2 | C8H8O | 详情 | 详情 |
(IV) | 18327 | benzyl(chloro)magnesium | 6921-34-2 | C7H7ClMg | 详情 | 详情 |
(V) | 41763 | 1,2-diphenyl-2-propanol | 5342-87-0 | C15H16O | 详情 | 详情 |
(VI) | 41764 | 1-methyl-1,2-diphenylethylformamide | C16H17NO | 详情 | 详情 | |
(VII) | 41765 | 1-methyl-1,2-diphenylethylamine; 1,2-diphenyl-2-propanamine | C15H17N | 详情 | 详情 | |
(VIII) | 18066 | N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid | 4530-20-5 | C7H13NO4 | 详情 | 详情 |
(IX) | 41766 | [(tert-butoxycarbonyl)amino]acetic 1,1-dimethylpropionic anhydride | C12H21NO5 | 详情 | 详情 | |
(X) | 41767 | tert-butyl 2-[(1-methyl-1,2-diphenylethyl)amino]-2-oxoethylcarbamate | C22H28N2O3 | 详情 | 详情 | |
(XI) | 11296 | 2-Chloroacetyl chloride; Chloroacetic chloride | 79-04-9 | C2H2Cl2O | 详情 | 详情 |
(XII) | 41768 | 2-chloro-N-(1-methyl-1,2-diphenylethyl)acetamide | C17H18ClNO | 详情 | 详情 |